Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,532.00    0.00 (0.00%)
Bid:
2,000.00
Ask:
2,782.00
Spread: 782.00 (39.10%)
Market Cap: £8.13b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

16 Dec 2015 07:00

RNS Number : 1475J
Bunzl PLC
16 December 2015
 



 

16 December 2015

 

BUNZL PRE CLOSE STATEMENT AND ACQUISITIONS IN FRANCE, CHILE AND SPAIN

 

Bunzl plc, the international distribution and outsourcing Group, is updating the market today relating to the year ending 31 December 2015 prior to entering its close period.

 

Overall trading is consistent with expectations at the time of the third quarter trading statement in October. At constant exchange rates, Group revenue growth for the year is expected to be approximately 5%, principally due to the positive impact of acquisitions together with some organic growth which continues to be affected by price declines on plastic resin based products, particularly in North America. The Group operating margin should be at the same level as the prior year.

 

Acquisitions continue to be a key part of the Company's strategy for growth and Bunzl also today announces that it has purchased three further businesses in France, Chile and Spain.

 

Comatec SAS, which is based in Carcassonne, France, is engaged in the distribution of high-end, innovative single use tableware to restaurants and hotels throughout France but also exports products to a large number of distributors in a number of countries worldwide. Revenue in the year ended 31 December 2015 is expected to be €19 million.

 

Bunzl has also acquired Emilio Saray Y Compania Limitada, trading as DPS, a distributor of catering disposables and a variety of cleaning, safety and packaging products based in Santiago with a number of other locations throughout Chile. Customers include wholesalers and distributors as well as restaurants, supermarkets and other end users. Revenue in 2015 is expected to be CLP25.4bn (c.£24 million).

 

Finally in Spain the Company has purchased Faru S.L. Based in Zaragoza, the business is engaged in the sale of personal protection equipment, including fall arrest and head protection products and safety shoes, to distributors throughout Spain. Revenue in 2015 is expected to be €5 million.

 

The Company has now acquired 21 businesses so far this year with a total committed acquisition spend of £320 million which is a record level of spend for Bunzl in any one year. Bunzl's strong cash flow and balance sheet and the continuing promising pipeline of further acquisition opportunities should enable the Group to consolidate further the markets in which it competes and continue to increase shareholder value.

 

Commenting on the acquisitions, Michael Roney, Chief Executive of Bunzl, said:

 

"The acquisition of Comatec is a significant addition to our strong business in France and expands our operations into the foodservice sector where we are already a leader in many countries. The purchase of DPS in Chile extends our business there into the foodservice and cleaning and hygiene sectors in a country where we have previously built a strong anchor position in the safety sector. Faru will complement our existing safety business in Spain by further enhancing our product offering. We are pleased to welcome the employees of all three businesses to the Group."

 

Enquiries:

Bunzl plc

Michael Roney, Chief Executive

Brian May, Finance Director

Tel: +44 (0)20 7725 5000

Tulchan

David Allchurch

Stephen Malthouse

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBSBDDGBBBGUU
Date   Source Headline
30th Mar 20204:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20202:00 pmRNS2020 AGM update
20th Mar 20208:00 amRNSAdditional Listing
19th Mar 20204:20 pmRNSDirector/PDMR Shareholding
12th Mar 20203:37 pmRNSAnnual Financial Report
10th Mar 20205:08 pmRNSDirector/PDMR Shareholding
9th Mar 20207:00 amRNSAcquisition
4th Mar 20205:05 pmRNSDirector/PDMR Shareholding
3rd Mar 202012:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20204:51 pmRNSDirector/PDMR Shareholding
2nd Mar 20204:45 pmRNSTotal Voting Rights
24th Feb 20207:00 amRNSFinal Results
24th Feb 20207:00 amRNSAcquisition
21st Feb 20205:10 pmRNSDirector Declaration
5th Feb 20207:00 amRNSDirector/PDMR Shareholding
3rd Feb 20205:29 pmRNSTotal Voting Rights
14th Jan 20206:05 pmRNSDirector/PDMR Shareholding
9th Jan 20207:00 amRNSAcquisition
2nd Jan 20203:20 pmRNSTotal Voting Rights
23rd Dec 20197:17 amRNSDirector Declaration
17th Dec 20197:00 amRNSTrading Statement
12th Dec 20198:00 amRNSAdditional Listing
6th Dec 20198:00 amRNSAdditional Listing
4th Dec 20193:45 pmRNSDirector/PDMR Shareholding
2nd Dec 201912:00 pmRNSTotal Voting Rights
4th Nov 20195:00 pmRNSDirector/PDMR Shareholding
1st Nov 201910:50 amRNSTotal Voting Rights
1st Nov 201910:30 amRNSBlock listing Interim Review
23rd Oct 20194:00 pmRNSDirector/PDMR Shareholding
22nd Oct 20197:00 amRNSTrading Statement
11th Oct 20193:30 pmRNSDirector/PDMR Shareholding
8th Oct 20195:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20195:23 pmRNSDirector/PDMR Shareholding
2nd Oct 20193:47 pmRNSHolding(s) in Company
2nd Oct 20199:11 amRNSDirector Declaration
1st Oct 201911:15 amRNSTotal Voting Rights
11th Sep 20195:41 pmRNSDirector/PDMR Shareholding
11th Sep 20195:40 pmRNSDirector/PDMR Shareholding
5th Sep 20194:50 pmRNSDirector/PDMR Shareholding
5th Sep 20198:00 amRNSAdditional Listing
2nd Sep 201910:30 amRNSTotal Voting Rights
27th Aug 201910:00 amRNSDividend Declaration
27th Aug 20197:00 amRNSHalf-year Report
2nd Aug 20194:35 pmRNSDirector/PDMR Shareholding
1st Aug 201910:10 amRNSTotal Voting Rights
24th Jul 201910:45 amRNSHolding(s) in Company
19th Jul 20194:58 pmRNSHolding(s) in Company
9th Jul 20194:57 pmRNSDirector/PDMR Shareholding
4th Jul 201910:40 amRNSDirector/PDMR Shareholding
1st Jul 20199:30 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.